Home > Insider Trading > Filing (0000879169-25-000085)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
879169	Incyte Corp	INCY	Services-Commercial Physical & Biological Research (8731)	943136539

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673776	H Steven Stein	1801 Augustine Cut-Off Wilmington DE 19803	Evp & Chief Medical Officer	No	Yes	No	No

Transaction Summary

Sold:	14,952 shares	Avg. Price: $68.47	Total Value: $1,023,763.44
Number of Shares After Transactions:	106,592 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2025-07-14	14,952	$68.47	97,466	No	4	S	Direct
Common Stock	Disposition	2025-07-14	1,555	$69.98	95,911	No	4	F	Direct
Common Stock	Disposition	2025-07-15	1,596	$68.25	94,315	No	4	F	Direct
Common Stock	Acquisiton	2025-07-15	12,277	$0.00	106,592	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	F	Direct
No	4	F	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Shares	Acquisiton	2025-07-15	30,692	$0.00	30,692	$0.00
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2025-07-15	27,629	$0.00	27,629	$68.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
30,692		2028-07-15	No	4	A	Direct
27,629		2035-07-14	No	4	A	Direct

Footnotes

Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Including the July 15, 2025 grant, this includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.